We demonstrated similar effects in MM and DLBCL cells using RSL3, a small molecule inhibitor that directly inhibits GPX4 by binding to the catalytic selenocysteine residue of the enzyme (Figure 1A). The gene discussed is GPX4; the disease is Miyoshi myopathy.